VEGFR2-targeted antibody fused with IFN mut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity-Reference-Cited by-同舟云学术

VEGFR2-targeted antibody fused with IFN mut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity

Published:2021-02 Issue:2 Volume:11 Page:420-433
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Shang Pengzhao,Gao Rui,Zhu Yijia,Zhang Xiaorui,Wang Yang,Guo Minji,Peng Hui,Wang Min,Zhang Juan

Funder

“Double First-Class” University Project

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Postgraduate Research & Practice Innovation Program of Jiangsu Province

National Students’ Platform for Innovation and Entrepreneurship Training Program

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference48 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Colorectal cancer liver metastases—understanding the differences in the management of synchronous and metachronous disease;Tan;Ann Acad Med Singapore,2010

3. Metronomic chemotherapy in metastatic colorectal cancer;Woo;Canc Lett,2017

4. Phase IB study of vemurafenib in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with BRAFV600E mutation;Hong;Canc Discov,2016

5. FDA approval summary: ramucirumab for gastric cancer;Casak;Clin Canc Res,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview;Pharmaceutics;2024-07-24

2. Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433];Acta Pharmaceutica Sinica B;2024-06

3. Anti–VEGFR2-Interferon α Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5;Journal of Immunotherapy;2024-04-24

4. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives;Journal of Translational Medicine;2024-01-16

5. Multifunctional nanoparticle-mediated combining therapy for human diseases;Signal Transduction and Targeted Therapy;2024-01-01